P-GLYCOPROTEIN INHIBITION EXACERBATES PACLITAXEL NEURONAL TOXICITY IN NEURONS AND CANCER PATIENTS.

被引：0
|
作者：
Stage, T. [1 ]
Khalaf, S. [1 ]
Steffensen, V. [1 ]
Hammer, H. [2 ]
Xiong, C. [3 ]
Nielsen, F. [1 ]
Poetz, O. [2 ]
Svenningsen, A. [1 ]
Rodriguez-Antona, C. [4 ]
Kroetz, D. [3 ]
机构：
[1] Univ Southern Denmark, Odense, Denmark
[2] Signatope, Reutlingen, Germany
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Spanish Natl Canc Res Ctr CNIO, Hereditary Endocrine Canc Grp, Madrid, Spain
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OIII-001
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [31] P-glycoprotein Inhibition for Optimal Drug Delivery
    Amin, Md. Lutful
    DRUG TARGET INSIGHTS, 2013, 7 : 27 - 34
  • [32] Identification of P-Glycoprotein and Transport Mechanism of Paclitaxel in Syncytiotrophoblast Cells
    Lee, Na-Young
    Lee, Ha-Eun
    Kang, Young-Sook
    BIOMOLECULES & THERAPEUTICS, 2014, 22 (01) : 68 - 72
  • [33] Effect of coumarin derivative-mediated inhibition of P-glycoprotein on oral bioavailability and therapeutic efficacy of paclitaxel
    Lee, Kyeong
    Chae, Song Wha
    Xia, Yan
    Kim, Na Hyung
    Kim, Hyun Ju
    Rhie, Sandy
    Lee, Hwa Jeong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723 : 381 - 388
  • [34] A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer
    Chi, KN
    Chia, SK
    Dixon, R
    Newman, MJ
    Wacher, VJ
    Sikic, B
    Gelmon, KA
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (04) : 311 - 315
  • [35] A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer
    Kim N. Chi
    Stephen K. Chia
    Ross Dixon
    Michael J. Newman
    Vince J. Wacher
    Branimir Sikic
    Karen A. Gelmon
    Investigational New Drugs, 2005, 23 : 311 - 315
  • [36] P-glycoprotein multidrug resistance and cancer
    Bosch, I
    Croop, J
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1288 (02): : F37 - F54
  • [37] Rauwolfia serpentina in P-Glycoprotein Inhibition of Cancer & Diabetes- A Computational Study
    Roy, Chandana
    Ganguli, Sayak
    Ghosh, Pratiti
    INTERNATIONAL JOURNAL OF AYURVEDIC MEDICINE, 2024, 15 (04) : 869 - 878
  • [38] Gender differences in p-glycoprotein:: Drug toxicity and response
    Davis, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) : 6439 - 6440
  • [39] P-Glycoprotein Inhibition Sensitizes Human Breast Cancer Cells to Proteasome Inhibitors
    Deshmukh, Rahul R.
    Kim, Seongho
    Elghoul, Yasmine
    Dou, Q. Ping
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (05) : 1239 - 1248
  • [40] Effective therapy of advanced breast cancer through synergistic anticancer by paclitaxel and P-glycoprotein inhibitor
    Zhu, Sifeng
    Sun, Chao
    Cai, Zimin
    Li, Yunyan
    Liu, Wendian
    Luan, Yun
    Wang, Cheng
    MATERIALS TODAY BIO, 2024, 26
12345